A U.S. appeals court on Tuesday revived a whistleblower lawsuit accusing ​four ‌large drugmakers of defrauding the federal and state governments out of hundreds of millions of ⁠dollars by overcharging ...

Whistleblower employee concept and whistle blower symbol representing a person in society or a company exposing corruption as a red whistle shaped as a human head in a 3D illustration style. The IRS ...

GSK struck a $950 million deal to buy Canada’s 35Pharma, a biopharmaceutical company developing cardiopulmonary treatments, as the U.K. drugmaker seeks to bolster its exposure to diseases linked to ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Building up its base of medicines for lung diseases, GSK said ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bora Pharmaceuticals Co., Ltd. (“Bora”; TWSE: 6472; OTCQX: BORAY), a global leader in pharmaceutical manufacturing, and GSK (LSE/NYSE: GSK) have signed a ...

The Government Accountability Office (GAO) has launched an investigation into the Department of Homeland Security’s (DHS) handling of whistleblower complaints following a string of complaints about ...

Following a more than decade-long legal back-and-forth over the generic drug carveout practice known as “skinny” labeling, GSK and Teva have put their dispute to bed, new court documents show. In a ...

GSK is buying RAPT Therapeutics for US$2 billion, for access to the company’s anti-immunoglobulin E (IgE) antibody ozureprubart. The antibody, a phase II candidate, could offer a long-acting option ...

A whistleblower complaint alleging wrongdoing by Director of National Intelligence Tulsi Gabbard was based on the intercept of a conversation between two foreign citizens discussing a person close to ...

GSK (GSK) shares clocked seven straight sessions of gains, as the stock rose 1.7% at $60.19 on Friday. The multinational healthcare giant gained 16.8% in the preceding six sessions. The stock has ...

GSK Plc’s new chief executive officer plans to speed up research and development and look for acquisitions as the British drugmaker tries to convince investors it can offset a looming patent cliff.

(RTTNews) - British drug major GSK plc (GSK, GSK.L) reported Wednesday higher profit and revenues in its fourth quarter, and issued fiscal 2026 outlook, expecting increase in core profit and turnover.